Coverage Decisions for Expensive Hemophilia Treatments
Russell P. Gollard, MD, FACP, discusses coverage decisions for expensive treatments in hemophilia, including total cost of care, drug availability, and real-world evidence.
Stay updated with breaking news from Drug Availability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Russell P. Gollard, MD, FACP, discusses coverage decisions for expensive treatments in hemophilia, including total cost of care, drug availability, and real-world evidence.
The initiative was launched in 2017 and involves the Ministry of Health & Family Welfare, Indian Council of Medical Research, State Governments, and WHO-India. India was among more than 40 low- and middle-income countries, including Bangladesh, Cuba and Sri Lanka, which have strengthened their hypertension care. All the LMICs have together enrolled more than 17 million people into treatment programmes, WHO said in its report.
The Indian Hypertension Control Initiative (IHCI) has treated around 5.8 million hypertension patients across 27 states in India. The availability of medicines has been identified as the main challenge.
To intensify hypertension control activities in the state, Punjab Health and Family Welfare Department on Friday released Hypertension and Diabetes Control Protocol during a state-level orientation training on Indian Hypertension Control Initiative (IHCI). The protocol was jointly released
Allowing generics for covid-19 in poor countries is a great marketing move for Merck.